Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 109060
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.109060
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.109060
Figure 1 Flowchart of the study population selection based on the National Health Insurance Service data for hepatocellular carcinoma.
HCC: Hepatocellular carcinoma; ICD: International Classification of Diseases; NHIS: National Health Insurance Service.
Figure 2 Trends of patients with hepatocellular carcinoma.
A: Diagnosed region; B: Treatment region.
Figure 3 Medical travel of patients with hepatocellular carcinoma.
A: Out of the region (efflux) for treatment; B: Into the region (influx) for treatment; C: Proportion of patients who traveled out of diagnosed areas; D: Proportion of patients who traveled to different regions for management.
Figure 4
Distribution of healthcare service utilization across regions based on patient residency.
- Citation: Kim S, Kim N, Lee HS, Kim M, Kim H, Choi Y. Medical travel patterns for hepatocellular carcinoma treatment in South Korea: National Health Insurance data from 2013 to 2021. World J Gastrointest Oncol 2025; 17(9): 109060
- URL: https://www.wjgnet.com/1948-5204/full/v17/i9/109060.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.109060